The future of CNS drug development: signs of real progress
Drug Target Review
JULY 21, 2025
Viral vectors use a virus’s blueprint to deliver genetic material into cells. To qualify for this designation, a drug candidate must meet the definition of regenerative medicine therapy, intend to treat or cure a serious condition, and be supported by preliminary clinical evidence that indicates it can address the clinical need.
Let's personalize your content